drug prices biologics drug costs IRA money cash payment co-pay
Pharma

White House unveils next round of MFN drug pricing deals

At the dealmaking table this time are Alcon, Astellas, BeOne Medicines, BridgeBio, CSL, Kyowa Kirin, Sun Pharma, Teva and UCB.
Fraiser Kansteiner Aug 31, 2026 5:10pm
video
Why real-world data is becoming a strategic asset in drug development

Why real-world data is becoming a strategic asset in drug development

Brought to you by LabCorp
Headshot of Lonzas Samanta Cimitan

Lonza enlists returning exec for new commercial chief post

Aug 31, 2026 3:20pm
Pharma Doesnt Have an AI Problem It Has an Information Problem

Pharma Doesn't Have an AI Problem. It Has an Information Problem.

Brought to you by Intelligencia AI
patent infringement patent lawsuit lawsuit

Ascendis pays 20% royalties in patent settlement with BioMarin

Aug 31, 2026 1:56pm
HCP medias endemic-versus-reach debate misses the real question

HCP media’s endemic-versus-reach debate misses the mark

Brought to you by Phreesia Network Solutions
More News

Jazz’s Ziihera secures 2nd survival win in HER2+ stomach cancer

Aug 31, 2026 10:17am

FDA approves label expansion for PharmaEssentia's Besremi

Aug 31, 2026 8:25am

ESC: AZ digs deep on Wainua's surprise ph. 3 failure in ATTR-CM

Aug 29, 2026 1:35pm

Takeda wins FDA nod for first-in-class blood cancer drug Mimrylo

Aug 28, 2026 10:04pm